Under the agreement, Moderna will supply these mRNA variant-targeting shots for Gavi at the lowest of its tiered prices. The shots will then be distributed to poor countries through the Covax facility, backed by the
Gavi will also cancel the delivery of remaining volumes of vaccines under a previous agreement as health providers shift to updated shots that work ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.